D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation - observations from the ARISTOTLE trial

Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS_2 Score: A Subgroup Analysis of the RE-LY Trial

(2013) Jonas Oldgren   ANNALS OF INTERNAL MEDICINE

Diagnosis of DVT

(2012) Shannon M. Bates et al.   CHEST

Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation

(2012) Ziad Hijazi et al.   CIRCULATION

Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation

(2012) Leif Friberg et al.   CIRCULATION

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study

(2012) Leif Friberg et al.   EUROPEAN HEART JOURNAL

Serum D-dimer as a predictor of mortality in patients with acute spontaneous intracerebral hemorrhage

(2012) Chun-Cheng Chiu et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Preoperative plasma D-dimer predicts 1-year survival in colorectal cancer patients with absence of venous thromboembolism (VTE): a prospective clinical cohort study

(2012) M. T. STENDER et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial

(2012) Renato D Lopes et al.   LANCET

D-Dimer Assays in Diagnosis and Management of Thrombotic and Bleeding Disorders

(2012) Shannon Bates   SEMINARS IN THROMBOSIS AND HEMOSTASIS

PAI-1 and t-PA/PAI-1 complex potential markers of fibrinolytic bleeding after cardiac surgery employing cardiopulmonary bypass

(2012) Agnese Ozolina et al.   BMC Anesthesiology

Anticoagulation Control Quality Affects the D-Dimer Levels of Atrial Fibrillation Patients

(2011) Yosuke Nakatani et al.   CIRCULATION JOURNAL

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale

(2010) Renato D. Lopes et al.   AMERICAN HEART JOURNAL

Predicting left atrial thrombi in atrial fibrillation

(2010) Waldemar E. Wysokinski et al.   AMERICAN HEART JOURNAL

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

(2010) Ron Pisters et al.   CHEST

Significance of fibrinogen, D-dimer, and LDH levels in predicting the risk of bleeding in patients with acute promyelocytic leukemia

(2010) Dae-Young Kim et al.   LEUKEMIA RESEARCH

Effect of apixaban, an oral and direct factor Xa inhibitor, on coagulation activity biomarkers following acute coronary syndrome

(2010) John Alexander et al.   THROMBOSIS AND HAEMOSTASIS

Apixaban decreases coagulation activity in patients with acute deep-vein thrombosis

(2010) Y. C. Barrett et al.   THROMBOSIS AND HAEMOSTASIS

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

(2009) Gregory Y.H. Lip et al.   CHEST

Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation

(2009) L. Friberg et al.   EUROPEAN HEART JOURNAL

D-Dimer and Prothrombin Fragment 1 + 2 Predict Venous Thromboembolism in Patients With Cancer: Results From the Vienna Cancer and Thrombosis Study

(2009) Cihan Ay et al.   JOURNAL OF CLINICAL ONCOLOGY

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of Risk Stratification Schemes to Predict Thromboembolism in People With Nonvalvular Atrial Fibrillation

(2008) Margaret C. Fang et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY